# The Efficacy and Safety of Zhigancao Tang Granule for HFpEF of Qi-Yin Dificiency

> **NCT04317339** · PHASE2 · UNKNOWN · sponsor: **Shanghai University of Traditional Chinese Medicine** · enrollment: 122 (estimated)

## Conditions studied

- Heart Failure With Preserved Ejection Fraction

## Interventions

- **DRUG:** Zhigancao Tang granule
- **DRUG:** Zhigancao Tang placebo granule

## Key facts

- **NCT ID:** NCT04317339
- **Lead sponsor:** Shanghai University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-20
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 122 (ESTIMATED)
- **Last updated:** 2020-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04317339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04317339, "The Efficacy and Safety of Zhigancao Tang Granule for HFpEF of Qi-Yin Dificiency". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04317339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*